Meta-analysis of morbidity and mortality in five exercise capacity trials evaluating ramipril in chronic congestive cardiac failure

American Journal of Cardiology

Volumn 77, Issue 14, 1996, Pages 1191-1196

  Lubsen, Jacobus ^a   Chadha, Dev R ^b   Yotof, Yoto T ^b   Swedberg, Karl ^b  

^a SOCAR RESEARCH SA   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RAMIPRIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXERCISE; EXERCISE TEST; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029973499     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00161-0     Document Type: Article

References (16)

1. Todd PA, Benfield P. Ramipril: a review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders. Drugs 1990;39:110-135.
2. Pfeffer MA, Braunwald E, Moyé LA, Basta L, Brown EJ, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GE, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH, Hawkins CM, on behalf of the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992;327:669-677.
3. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821-828.
4. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-1435.
5. Cohn J, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M, Bhat G, Goldman S, Fletcher RD, Doherty J, Hughes CV, Carson P, Cintron G, Shabetai R, Haakenson C. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303-310.
6. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991;325:293-302.
7. Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis and Diseases of the Heart and Great Vessels. 7th ed. Boston: Little Brown, 1973.
8. Patterson JA, Naughton J, Pietras RJ, Gunnar RM. Treadmill exercise in assessment of the functional capacity of patients with cardiac disease. Am J Cardiol 1972;30:757-762.
9. Rothman KJ. Modern Epidemiology. Boston: Little Brown & Co, 1986.
10. Woolf B. On estimating the relationship between blood group and disease. Ann Hum Genet 1954;19:251-253.
11. Cochran WG. Some methods for strengthening the common chi-square tests. Biometrics 1954;10:417.
12. Breslow NE, Day NE. Statistical Methods in Cancer Research. Vol. 1: The Analysis of Case-Control Studies. Lyon: International Agency for Research on Cancer, 1980.
13. Conover WJ. Practical Nonparametric Statistics. 2nd ed. New York: John Wiley & Sons, 1980.
14. Tukey JW. The future of data analysis. Ann Math Statistics 1962;32:22.
15. Pocock SJ. Clinical Trials: A Practical Approach. Chichester: John Wiley, 1983.
16. Lubsen J. Exercise testing as outcome in congestive heart failure trials: design considerations when interpreting results. Drugs 1994;47 (suppl 4):25-30.